Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales1 4211 4001 5091 5971 7291 891
Operating income (EBITDA)273280315357411458
Operating profit (EBIT)183190224260303356
Pre-Tax Profit (EBT)------
Net income12795,6144188222268
P/E ratio30,446,344,432,227,522,8
EPS ( $ )1,751,301,912,522,953,55
Dividend per Share ( $ )0,410,460,500,540,580,62
Yield0,77%0,76%0,59%0,66%0,71%0,76%
Reference price ( $ )53.2460.2284.8381.181.181.1
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt--25,6---
Finance---80,037,056,0
Operating income (EBITDA)273280315357411458
Leverage
(Debt/EBITDA)
--0,08x---
Capital Expenditure-132170160160160
Book Value Per Share (BVPS)-14,2 $15,3 $16,8 $18,4 $20,7 $
Cash Flow per Share2,51 $2,88 $2,93 $3,68 $4,15 $-
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 5 947 M$ -
Entreprise Value (EV) 5 867 M$ 5 910 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 32,2x 27,5x
Capitalization / Revenue 3,72x 3,44x
EV / Revenue 3,67x 3,42x
EV / EBITDA 16,4x 14,4x
Yield (DPS / Price) 0,66% 0,71%
Price to book (Price / BVPS) 4,83x 4,41x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 16,3% 17,5%
operating Leverage (Delta EBIT / Delta Sales) 2,75x 2,01x
Net Margin (Net Profit / Revenue) 11,8% 12,8%
ROA (Net Profit / Asset) 9,90% 11,3%
ROE (Net Profit / Equities) 15,0% 16,1%
Rate of Dividend 21,3% 19,5%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   10,0% 9,25%
Cash Flow / Sales 16,9% 17,6%
Capital Intensity (Assets / Sales) 1,19x 1,13x
Financial Leverage (Net Debt / EBITDA) -0,22x -0,09x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend